Biote announces expiration and results of exchange offer and consent solicitation relating to warrants

Irving, texas--(business wire)--biote (nasdaq: btmd) (the “company,” “we” or “us”), a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today announced the expiration and results of its previously announced (i) offer to each holder of its outstanding warrants, each whole warrant exercisable for one share of class a common stock, par value $0.0001 per share (“common stock”), of the company, at an exercise price of $11.50 per share (the “war.
BTMD Ratings Summary
BTMD Quant Ranking